Related by context. All words. (Click for frequent words.) 79 FOLFOX4 77 ACTEMRA TM 77 plus gemcitabine 77 plus prednisone 76 alfa 2a 76 chlorambucil 76 FOLFOX 76 docetaxel chemotherapy 75 Peg IFN 75 5-FU/LV 74 Flu Cy 74 placebo dexamethasone 74 8mg/kg 74 FOLFIRI 74 Folfox 74 Fludara 74 Doxil ® 73 lopinavir r arm 73 FluCAM 73 clodronate 73 achieved ACR# 73 ribavirin RBV 73 infusional 5-FU/LV 73 oral allopurinol 73 CIMZIA TM 73 dacarbazine 72 pegylated interferon alpha 72 FOLFOX4 alone 72 XELOX 72 infliximab monotherapy 72 sorafenib Nexavar ® 72 pegylated liposomal doxorubicin 72 dacarbazine DTIC 72 interferon alfa 2a 72 telaprevir dosed 72 carboplatin paclitaxel 72 low dose cytarabine 72 VELCADE melphalan 72 5 FU leucovorin 72 Xeloda ® 72 evaluating tivozanib 72 gemcitabine carboplatin 72 YERVOY 72 mcg QD 71 receiving INTRON 71 comparator arm 71 Jevtana 71 lopinavir r 71 PREZISTA ritonavir 71 PREZISTA r 71 gemcitabine chemotherapy 71 pegylated interferon alfa 2b 71 mcg kg REBETOL 71 pegylated interferon alfa 2a 71 adjunctive placebo 71 FOLFIRI alone 71 CR nPR 71 Pegasys peginterferon alfa 2a 71 FOLFOX6 71 CIMZIA ™ 70 standard chemotherapy regimen 70 stage IIIb IV 70 metastatic GIST 70 peginterferon alfa 2b 70 CANCIDAS 70 tenofovir emtricitabine 70 Taxotere ® 70 Median PFS 70 oxycodone CR 70 relapsed MM 70 trastuzumab Herceptin R 70 TO AVOID PREGNANCY WHILE 70 Free Survival PFS 70 cyclophosphamide chemotherapy 70 PEGINTRON TM 70 oral diclofenac 70 Pegasys ® 70 adriamycin 70 KRAS mutations occur 70 Gemzar ® 70 relapsed refractory multiple myeloma 70 Elitek 70 Engerix B 70 ritonavir boosted atazanavir 70 TMC# r 70 oblimersen 70 docetaxel prednisone 70 cisplatin vinorelbine 70 q8h 70 LEXIVA r 70 plus ribavirin 70 sunitinib malate 70 daunorubicin 70 mapatumumab 70 abacavir lamivudine 70 decitabine 70 receiving prophylactic anticoagulation 70 Peginterferon 69 plus prednisone prednisolone 69 mRCC 69 docetaxel Taxotere ® 69 XIENCE V PROMUS Stent 69 mg kg dose 69 Aptivus ® 69 mcg BID 69 #mg BID [001] 69 DOXIL 69 mg QD 69 dose dexamethasone 69 Tarceva TM 69 ritonavir boosted 69 paclitaxel Taxol ® 69 estramustine 69 HBeAg negative patients 69 plus COPEGUS 69 4mg/kg 69 achieved CCyR 69 certolizumab 69 low dose dexamethasone 69 chemotherapy FOLFOX 69 cisplatin gemcitabine 69 free survival PFS 69 refractory NSCLC 69 SPRYCEL ® 69 CR CRu 69 Paraplatin ® 69 mg ustekinumab 69 Amrubicin 69 doxazosin 69 plus methotrexate 69 pegylated interferon peg IFN 69 bendamustine 69 salmeterol fluticasone 69 Copegus ribavirin 69 melphalan prednisone 69 biologic DMARD 69 capecitabine Xeloda 69 patients receiving ERBITUX 69 relapsed myeloma 69 Alkeran 69 dexamethasone Decadron 69 achieved PASI 69 Ixempra 69 ZACTIMA 69 LPV r 69 TORISEL 69 rizatriptan 69 azacitidine 69 FEMALES SHOULD BE ADVISED 69 mycophenolate mofetil 69 Navelbine ® 69 R# #mg BID 69 gemcitabine cisplatin 69 pegylated interferon alfa 69 dasatinib Sprycel ® 69 Fludara ® 69 erlotinib Tarceva ® 68 peginterferon alfa 2a Pegasys 68 oral chemotherapeutic agent 68 relapsed multiple myeloma 68 CCyR 68 docetaxel Taxotere R 68 cyclophosphamide doxorubicin vincristine 68 mg qd 68 unfractionated heparin UFH 68 fluticasone salmeterol 68 AVASTIN 68 Hycamtin ® 68 APTIVUS R 68 morphometric vertebral fractures 68 sorafenib Nexavar 68 ULORIC 68 mCRC patients 68 anthracycline taxane 68 oxaliplatin Eloxatin 68 recurrent glioblastoma multiforme 68 PEGylated Fab fragment 68 mg BID 68 goserelin 68 aspirin heparin 68 q#h 68 5 fluorouracil leucovorin 68 refractory chronic lymphocytic 68 interferon alfa 2b 68 mitoxantrone 68 vandetanib 68 cetuximab Erbitux R 68 ELOXATIN 68 gemcitabine 68 docetaxel 68 peginterferon alfa 2a 68 Median progression 68 mcg albinterferon alfa 2b 68 prednisone prednisolone plus 68 Camptosar ® 68 mitoxantrone plus 68 pegylated interferon 68 MabCampath 68 desvenlafaxine succinate 68 gefitinib 68 cabazitaxel 68 peg interferon 68 galiximab 68 temsirolimus 68 MCyR 68 Navelbine 68 octreotide LAR 68 FOLFOX6 chemotherapy regimen 68 interferon gamma 1b 68 highly emetogenic 68 teriflunomide 68 oral rivaroxaban 68 pertuzumab 68 metastatic CRC 68 HBeAg seroconversion 68 bevacizumab Avastin ® 68 mcg kg 68 nicardipine 68 HER2 positive metastatic breast 68 receiving PEGINTRON 68 lamivudine monotherapy 68 daily Infergen 67 PegIFN 67 fluorouracil 67 HBeAg positive patients 67 azathioprine 67 Xelox 67 Lenalidomide 67 COPEGUS 67 ACR# response 67 CHOP chemotherapy 67 IIIa inhibitor 67 complete cytogenetic response 67 gemcitabine Gemzar 67 receiving VICTRELIS 67 Zometa hazard 67 ABC/3TC 67 TAXUS p value 67 adalimumab Humira 67 AEGR 67 tapentadol ER 67 peg IFN 67 tipranavir r 67 plus OBT 67 doxorubicin cyclophosphamide 67 Pemetrexed 67 achieved sustained virologic 67 RGT arm 67 equi analgesic doses 67 Torisel 67 fluvastatin 67 unresectable stage 67 naïve HCV 67 cyclophosphamide methotrexate 67 3mg/kg 67 lispro 67 DexaSite 67 Ceplene/IL-2 67 paclitaxel Taxol R 67 metastatic renal cell carcinoma 67 TTF Therapy 67 rosuvastatin #mg 67 PegIntron 67 active comparator 67 Aflibercept 67 adjunctive ABILIFY 67 idraparinux 67 plus GP IIb 67 ® lenalidomide 67 pomalidomide 67 RECIST Response Evaluation Criteria 67 bortezomib Velcade R 67 FOLFIRI chemotherapy 67 docetaxel Taxotere 67 chemoradiation therapy 67 potent CYP#A# inhibitors 67 sustained virologic response 67 partial remissions 67 saline placebo 67 mitomycin 67 FUSILEV enhances 67 candesartan cilexetil 67 adefovir 67 ATACAND 67 ZOLINZA 67 efavirenz EFV 67 doxorubicin docetaxel 67 interferon alfa 67 TAXUS Express Stent 67 MAGE A3 ASCI 67 vinorelbine 67 achieved sustained virological 67 mCi kg 67 topotecan 67 Platinol ® 67 nab paclitaxel 67 bortezomib refractory 67 posaconazole 67 Hormone Refractory Prostate Cancer 67 metastatic castration resistant 67 median PFS 67 Peginterferon Alfa 2a 67 sorafenib tablets 67 monotherapy 67 BARACLUDE ® 67 adalimumab 67 5 Fluorouracil 67 methotrexate monotherapy 67 dasatinib Sprycel 67 APTIVUS r 67 interferon ribavirin 67 KRAS wild 67 FIRMAGON 67 nadroparin 67 elotuzumab 67 PEG IFN 67 splenectomized patients 67 pegylated interferon alpha 2a 67 mg m² 67 peginterferon 67 SVR# 67 Irinotecan 67 TYKERB 67 low dose Iluvien 67 recurrent GBM 67 REVLIMID ® 67 Vidaza ® 67 ARB telmisartan 66 peginterferon alfa 2a #KD 66 response CCyR 66 DOXIL ® 66 PREZISTA r arm 66 REYATAZ r 66 clopidogrel Plavix 66 nodular partial response 66 TLUS 66 refractory AML 66 humanized interleukin 6 66 doripenem 66 carboplatin 66 Mg Uk 66 Thal Dex 66 CIMZIA TM certolizumab pegol 66 rituximab refractory 66 % CI #.#-#.# [003] 66 amoxicillin clavulanate 66 Taxotere chemotherapy 66 REMICADE monotherapy 66 COMBIVIR 66 boosted protease inhibitor 66 Platinol ® cisplatin 66 treatment naïve genotype 66 piperacillin tazobactam 66 metastatic hormone refractory 66 mg/m2 dose 66 Targretin 66 leukemia AML 66 metastatic HRPC 66 biochemical relapse 66 TAXOTERE R 66 Gemcitabine 66 axitinib 66 chemoradiation 66 Randomized Phase 66 cetuximab Erbitux ® 66 placebo p = 66 oral Hycamtin 66 viral kinetics 66 dalteparin 66 TAXUS Liberte Long 66 microbiological eradication 66 PEG Interferon alfa 66 HCV RESPOND 2 66 doxorubicin HCl liposome injection 66 #mg BID [002] 66 rimonabant #mg 66 protease inhibitor PI 66 oral ridaforolimus 66 advanced hepatocellular carcinoma 66 capecitabine 66 nadolol 66 NPH insulin 66 irinotecan doxorubicin oxaliplatin paclitaxel 66 Newly Diagnosed Multiple Myeloma 66 ribavirin therapy 66 VIDAZA 66 adjuvant GIST 66 REYATAZ R 66 peginterferon alfa 66 dacarbazine chemotherapy 66 CYPHER Stent 66 hydroxymethyl coenzyme 66 Operative mortality 66 eribulin 66 baseline HbA1c 66 Hazard Ratio 66 complete cytogenetic 66 atazanavir ritonavir 66 vincristine doxorubicin 66 tirofiban 66 xanthine oxidase inhibitor 66 mg hydrochlorothiazide 66 paclitaxel chemotherapy 66 EGFR expressing mCRC 66 cisplatin chemotherapy 66 sorafenib Nexavar R 66 amrubicin 66 irinotecan chemotherapy 66 monoclonal antibody IgG1 Mab 66 IMiDs 66 dexamethasone 66 Pegasys plus Copegus 66 treatment naive genotype 66 PASI scores 66 PEG interferon 66 Pegylated Interferon 66 bevacizumab Avastin R 66 PEGylated anti 66 neurologic progression 66 plus aztreonam 66 dose melphalan 66 CoFactor 66 Platinol 66 Oral Fingolimod 66 STELARA ® 66 μg dose 66 budesonide pMDI 66 darunavir ritonavir 66 RLAI 66 5-fluorouracil/leucovorin 66 zolmitriptan 66 bosentan 66 tiotropium 66 5FU 66 imatinib Gleevec ® 66 thalidomide Thalomid 66 mg TID 66 irbesartan 66 log# IU mL 66 alpha 2b 65 oral levofloxacin 65 generalized edema 65 neoadjuvant 65 fluoropyrimidine 65 benazepril 65 paclitaxel cisplatin 65 abiraterone acetate 65 prostate cancer HRPC 65 paclitaxel carboplatin 65 #mg/m# [001] 65 febrile neutropenia 65 demonstrated antitumor activity 65 cytogenetic response 65 dose cytarabine 65 colesevelam HCl 65 Acetate Rectal Suppositories 65 primary hypercholesterolemia 65 evaluating REVLIMID 65 PROCTOCORT ® Suppository Hydrocortisone 65 sunitinib Sutent ® 65 Meets Primary Endpoint 65 VFEND 65 neoadjuvant chemotherapy 65 trastuzumab 65 titrated glipizide 65 #mg QD [002] 65 achieve sustained virologic 65 fluorouracil leucovorin 65 Solid Tumors criteria 65 moderate renal impairment 65 IFN alfa 65 virologic failure 65 levosimendan 65 oral clodronate 65 PegIFN RBV 65 postoperative chemotherapy 65 Bezielle 65 sunitinib 65 iniparib 65 #mg doses [002] 65 cytarabine daunorubicin 65 bosutinib 65 alteplase 65 FOLPI 65 aflibercept VEGF Trap 65 Topotecan 65 insulin detemir 65 NEUPOGEN 65 severe neutropenia 65 recurrent NSCLC 65 AZT zidovudine Retrovir 65 mcg dose 65 Raptiva r 65 R lenalidomide 65 induced macular edema 65 maximally tolerated dose 65 dabigatran etexilate 65 BRIM2 65 Peginterferon alfa 2b 65 #.#mg/dL 65 HCV SPRINT 65 degarelix 65 imipenem 65 Halaven 65 chemoradiotherapy 65 prednisone CHOP 65 preoperative chemotherapy 65 Sustained virologic response 65 Kaplan Meier analysis 65 Campath alemtuzumab 65 #mg BID [003] 65 REYATAZ r arm 65 Pegintron 65 gp# vaccine 65 Sandostatin R 65 serum urate 65 CRu 65 capecitabine Xeloda R 65 lenalidomide Revlimid R 65 Imprime PGG 65 flutamide 65 basiliximab 65 gefitinib Iressa 65 metastatic malignant 65 stage IIIB 65 KRAS mutant tumors 65 PEGASYS ® 65 peripheral sensory neuropathy 65 beclomethasone dipropionate 65 imatinib Gleevec 65 cilengitide 65 GOUT 65 Neulasta R 65 de novo kidney transplant 65 idarubicin 65 PEG Intron 65 Omacetaxine 65 zidovudine lamivudine 65 Degarelix 65 remission CR 65 FOR FURTHER INFORMATION ABOUT 65 dasatinib 65 R sorafenib tablets 65 Severe Sepsis 65 REVLIMID R 65 bortezomib 65 Heterozygous Familial Hypercholesterolemia 65 nitazoxanide 65 RoACTEMRA 65 somatostatin analog 65 FOLFOX chemotherapy 65 ABVD 65 Doxil 65 mcg linaclotide 65 lumbar spine BMD 65 refractory cutaneous T 65 liposomal formulation 65 pemetrexed 65 Lupuzor ™ 65 CRp 65 non splenectomized 65 Xeloda capecitabine 65 NATRECOR R 65 cinacalcet 65 mg dose 65 Trastuzumab 65 chemotherapy gemcitabine 65 subcutaneously administered 65 R adefovir dipivoxil 65 relapsing multiple sclerosis 65 DAS# remission 65 patients evaluable 65 MGd 65 pegylated alpha interferon 65 tocilizumab 65 oxycodone IR 65 TREANDA 65 #mg/day [001] 65 PROMACTA 65 Nilotinib 65 Adjuvant Treatment 65 azilsartan medoxomil 65 lapatinib Tykerb 65 alpha 2a 65 evaluable patients 65 azacytidine 65 Gleevec Glivec 65 YONDELIS 65 Taxotere R 65 Dabigatran etexilate 65 QTcF 65 IFL chemotherapy regimen 65 alfuzosin 65 Velcade bortezomib 65 3TC lamivudine Epivir 65 recurrent glioblastoma 65 divalproex sodium 65 PEG INTRON 65 Elotuzumab 64 relapsed CLL 64 Ophena TM 64 ritonavir boosted lopinavir 64 locoregional recurrence 64 rilpivirine 64 Brentuximab Vedotin SGN 64 hormone refractory metastatic prostate 64 omega interferon 64 lenalidomide 64 mg RDEA# 64 vidofludimus 64 VIRAMUNE 64 lenalidomide Revlimid ® 64 Fludarabine 64 % Confidence Interval 64 Tipranavir 64 Natalizumab 64 plus 5-FU/LV 64 adefovir dipivoxil 64 carboplatin chemotherapy 64 receiving highly emetogenic 64 Pivotal Phase III 64 -#.# log# copies mL 64 TPV r 64 tolterodine ER 64 EGFR TKI 64 locoregional disease 64 anthracyclines taxanes 64 fludarabine 64 noninferior 64 afatinib 64 zalutumumab 64 BENICAR 64 Neoadjuvant 64 #mg dose [003] 64 LymphoStat B belimumab 64 Increlex ® 64 olmesartan 64 splenectomized 64 sorafenib 64 biliary tract cancer 64 Response Evaluation Criteria 64 eribulin mesylate 64 sustained virological response 64 atherothrombotic events 64 Herceptin trastuzumab 64 Antitumor Activity 64 brand ciclesonide HFA 64 icatibant 64 Targretin capsules 64 EDEMA3 64 intravenous bolus 64 undetectable HBV DNA 64 CTAP# Capsules 64 NEVO ™ 64 COPEGUS ribavirin 64 cetuximab Erbitux 64 drotrecogin alfa activated 64 BR.# 64 Prograf ® 64 prednisone prednisolone 64 Bevacizumab 64 melphalan 64 EPIVIR 64 peginterferon alpha 2a 64 blinded randomized placebo controlled 64 panitumumab 64 Erlotinib 64 log# copies mL 64 diabetic neuropathic pain 64 epirubicin cyclophosphamide 64 Fulvestrant 64 R rilonacept Injection 64 PKC# 64 insulin glulisine 64 aldosterone antagonists 64 enzastaurin 64 ALVESCO 64 dapagliflozin plus 64 squamous histology 64 ACR# responses 64 forodesine 64 PROCTOCORT R 64 ixabepilone 64 erlotinib Tarceva R 64 ARCOXIA 64 rapid virologic response 64 REBETOL 64 BENICAR HCT 64 IFN α 64 tacrolimus ointment 64 virus HCV protease inhibitor 64 angiographic outcomes 64 EFAPROXYN 64 Femara letrozole 64 TDF FTC 64 nilotinib 64 HGS# 64 recurrent malignant glioma 64 follicular NHL 64 Sandostatin LAR Depot 64 cEVR 64 aflibercept 64 zonisamide SR 64 #mg dose [002] 64 Pharmacokinetics PK 64 VIRAMUNE XR 64 lamivudine 64 aspirin clopidogrel 64 annualized relapse 64 Tamibarotene 64 pegylated interferons 64 ribavirin USP 64 Peginterferon alfa 2a 64 eplerenone 64 randomized Phase III 64 Temodar ® 64 refractory CLL 64 Copegus 64 CAELYX 64 paclitaxel Taxol 64 reinfarction 64 visilizumab 64 placebo PBO 64 Chronic Hepatitis C 64 custirsen 64 REVLIMID lenalidomide 64 dose cohorts 64 refractory multiple myeloma 64 dose cohort 64 Myelodysplastic Syndrome MDS 64 rFVIIa 64 Pegasys R 64 Study Evaluating 64 mg tid 64 PEGINTRON 64 -#.# log# 64 apremilast 64 Vectibix 64 FOLFOX regimen 64 INCB# [003] 64 mg BID dose 64 pain palliation 64 trabectedin 64 linaclotide treated 64 Nexavar sorafenib 64 Capecitabine 64 INFERGEN 64 steroid dexamethasone 64 atorvastatin #mg 64 refractory metastatic colorectal cancer 64 glufosfamide 64 fluconazole 64 resected pancreatic cancer 64 cediranib 64 ORENCIA ® 64 ARIMIDEX 64 Sirolimus eluting Coronary Stent 64 fenofibric acid 64 VICTRELIS 64 metastatic RCC 64 sirolimus eluting stent 64 rituximab Rituxan 64 Medoxomil 64 Contrave# 64 FluCAM arm 64 ARCALYST ® 64 chemotherapy docetaxel 64 DASISION 64 CorVue ™ 64 tamoxifen Nolvadex ® 64 tamsulosin 64 Mg Usa 64 definite stent thrombosis 64 TELCYTA 64 crizotinib PF # 63 azathioprine monotherapy 63 p = NS 63 leukemia CLL 63 TEMODAL 63 adjuvant radiation 63 mutated KRAS 63 mg/m2 IV 63 hypogonadal men 63 cell lymphoma CTCL 63 STELARA 63 BARACLUDE R 63 cyclophosphamide FC 63 sunitinib Sutent 63 efavirenz emtricitabine 63 regorafenib 63 + PH# 63 evaluable subjects 63 ACE inhibitor ramipril 63 BRAF inhibitor 63 relapsed SCLC 63 cancer mCRC 63 sirolimus eluting 63 Temsirolimus 63 adjuvant tamoxifen 63 tenecteplase 63 micafungin 63 abciximab 63 NATRECOR ® 63 severe exacerbations 63 Patients Treated With 63 invasive aspergillosis 63 Copegus ® 63 #mg/day [002] 63 adefovir treated 63 hA# 63 Epivir 63 ancrod 63 tipranavir 63 Raptiva ® 63 #mg/m# [002] 63 unfractionated heparin 63 Zevalin R Ibritumomab 63 Betaferon R 63 pamidronate 63 CTA# Injection 63 ARIXTRA 63 mm Stent 63 sipuleucel T 63 EBRT 63 carcinoma mCRC 63 Complicated Skin 63 clopidogrel Plavix ® 63 Trial Evaluating 63 metastatic colorectal carcinoma 63 alpha interferons 63 XGEVA 63 NAVISTAR R 63 everolimus tablets 63 PROSTVAC ® 63 progression TTP 63 autoantibody positive 63 deep venous thromboses 63 Betaferon ® 63 ibandronate 63 Perforomist Inhalation Solution 63 Median survival 63 Pharmacokinetic parameters 63 #mg #mg #mg [003] 63 non metastatic osteosarcoma 63 heavily pretreated 63 platinum refractory 63 amprenavir 63 metformin sulfonylurea 63 Traficet EN 63 binary restenosis 63 INTEGRILIN R 63 Procoralan 63 amphotericin B 63 ® bortezomib 63 Azacitidine 63 ONGLYZA saxagliptin 63 plus dacarbazine 63 Taxotere docetaxel 63 tiotropium bromide 63 APPRAISE 63 Golimumab 63 Ranibizumab 63 pCR 63 Clolar ® 63 prior chemotherapy regimens 63 lamivudine refractory patients 63 PEG INTRON R 63 folinic acid 63 Zorbtive TM 63 Pivotal Phase 63 recurrent VTE 63 Sprycel dasatinib 63 Virologic 63 Romiplostim 63 Rebif ® 63 mg q#h 63 voriconazole 63 INTELENCE 63 Prolongs Survival 63 bivalirudin 63 trastuzumab Herceptin ® 63 adult chronic ITP 63 discontinuations due 63 lamivudine 3TC 63 5 fluorouracil 63 EOquin TM phase 63 nilotinib Tasigna ® 63 ximelagatran 63 INC# 63 intravesical infusion therapy 63 CYT# potent vascular disrupting 63 sUA 63 ACZ# 63 AVONEX ® 63 DEB# 63 lenalidomide dexamethasone 63 Taxol ® 63 ezetimibe simvastatin 63 virologic response 63 PRN FDA Approves 63 AVODART 63 valsartan 63 CPOP R 63 EBMT criteria 63 velafermin 63 ACTEMRA 63 EOquin TM 63 neutropenic sepsis 63 pegylated interferon ribavirin 63 Cimzia TM 63 HBeAg + 63 Teriflunomide 63 Pegylated Liposomal Doxorubicin 63 TNF antagonists 63 chemotherapy cisplatin 63 EURIDIS 63 adecatumumab 63 enalapril 63 antiretroviral naive 63 metastatic castrate resistant 63 NS5B polymerase 63 PSA nadir 63 evaluating Xcytrin 63 Dasatinib 63 neutropenia dehydration dyspnea 63 glycoprotein IIb IIIa inhibitor 63 assessing T DM1 63 FAMPYRA 63 BEACOPP 63 esophageal candidiasis 63 angiotensin receptor blocker ARB 63 Achieves Primary Endpoint 63 MYDICAR ® 63 Relapsing Multiple Sclerosis 63 trabedersen 63 brivaracetam 63 LANTUS R 63 evaluable 63 bone marrow reticulin deposition 63 iniparib BSI 63 Monotherapy 63 Adalimumab 63 venlafaxine ER 63 complete remissions 63 Ziprasidone 63 liposome injection 63 heavily pretreated patients 63 etanercept 63 mg subcutaneous 63 mometasone furoate 63 valsartan amlodipine 63 FROVA 63 mg Proellex 63 low dose ritonavir 63 Adefovir 63 unresectable Stage III 63 leukemia ALL 63 refractory indolent non 63 paclitaxel eluting stents 63 follicular lymphomas 63 FASLODEX 63 Albuferon TM 63 remission induction 63 Cream USP 1 63 Tarceva erlotinib 63 RECIST criteria 63 mg/# h 63 IXEMPRA 63 zoledronate 63 APTIVUS 63 achieved statistical significance 63 achieving PASI 63 Relapsed Refractory Multiple Myeloma 63 GvHD 63 CLARITY study 63 Relapsed Refractory 63 seroprotection 63 alfa 2b 63 CALGB # [002] 63 Paraplatin 63 concurrent chemoradiation 63 TAXOTERE ® 63 MACUGEN 63 PRADAXA 63 NOXAFIL Oral Suspension 63 Castration Resistant Prostate Cancer 63 erlotinib 63 ALIMTA cisplatin 63 mg kg belimumab 63 abnormal p# biomarker 63 febuxostat 63 CYPHER ® Stent 63 TNF Tumor Necrosis Factor 63 malignancy HCM 63 Vfend 63 LUCENTIS 63 plus DOXIL 63 metformin HCl 63 prospectively defined